Literature DB >> 11241296

Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.

M V Tejada-Simon1, J Hong, V M Rivera, J Z Zhang.   

Abstract

Autoreactive T cells specific for candidate myelin antigens, including myelin basic protein (MBP) and proteolipid protein (PLP), are thought to play an important role in the pathogenesis of multiple sclerosis (MS). Myelin-reactive T cells primed in vivo by myelin breakdown products or microbial cross-reactive antigens during the disease processes may exhibit a reactivity pattern and cytokine profile different from those in the normal T cell repertoire. In this study, we examined the precursor frequency, the reactivity pattern and cytokine profile of myelin-reactive T cells that were primed in vitro with overlapping peptides of MBP and PLP in patients with MS and healthy individuals. The results revealed that T cells specific for peptides of MBP and PLP occurred at a relatively higher precursor frequency in patients with MS than that in healthy individuals. We identified a number of dominant T cell epitopes within MBP and PLP, some of which were not previously detected using whole myelin antigens as the primary stimuli. Some residues represented common immunodominant regions that were detected in both MS patients and healthy controls while others were associated only with MS. MBP-reactive T cell lines generally exhibited a Th0-like cytokine profile. There was significantly increased Th1 cytokine production (i. e. TNF and IFN-gamma) among MS-derived T cell lines. PLP-reactive T cell lines had a distinct cytokine profile, producing predominantly TNF-alpha and little or not IFN-gamma and IL-4. The findings have important implications in the understanding of the role of myelin-reactive T cells in MS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241296     DOI: 10.1002/1521-4141(200103)31:3<907::aid-immu907>3.0.co;2-1

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

3.  Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14.

Authors:  Zohar Ochanuna; Anat Geiger-Maor; Adi Dembinsky-Vaknin; Dimitrios Karussis; Mark L Tykocinski; Jacob Rachmilewitz
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

4.  T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

Authors:  Joan O'Keeffe; Carol M Gately; Timothy Counihan; Michael Hennessy; Teresa Leahy; Anthony P Moran; Edward L Hogan
Journal:  J Neurol Sci       Date:  2008-08-15       Impact factor: 3.181

5.  HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Authors:  L F Barcellos; J R Oksenberg; A B Begovich; E R Martin; S Schmidt; E Vittinghoff; D S Goodin; D Pelletier; R R Lincoln; P Bucher; A Swerdlin; M A Pericak-Vance; J L Haines; S L Hauser
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

6.  Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues.

Authors:  Soili A Saarelainen; Tuure T Kinnunen; Cécile Buhot; Ale T O Närvänen; Anu K Kauppinen; Marja A Rytkönen-Nissinen; Bernard Maillere; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-10-16       Impact factor: 7.397

7.  Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals.

Authors:  G Mazza; M Ponsford; P Lowrey; M J Campbell; J Zajicek; D C Wraith
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 8.  Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Christine Riedhammer; Robert Weissert
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

Review 9.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

10.  CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.

Authors:  Tobias Ruck; Stefan Bittner; Catharina C Gross; Johanna Breuer; Stefanie Albrecht; Sabrina Korr; Kerstin Göbel; Susann Pankratz; Christian M Henschel; Nicholas Schwab; Ori Staszewski; Marco Prinz; Tanja Kuhlmann; Sven G Meuth; Heinz Wiendl
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.